NMS-1286937 25mg
NMS-1286937 is an orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity.
| Trivial name | NMS-1286937 25mg |
| Catalog Number | A13045-25 |
| Alternative Name(s) | 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide |
| Molecular Formula | C24H27F3N8O3 |
| CAS# | 1034616-18-6 |
| SMILES | CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO |
| Size | 25mg |
| Supplier Page | http://www.adooq.com/nms-1286937.html |